Industry Reports
The Flatiron Health Acquisitio could make things better For Roche’s Oncology Real-World Evidence Needs
Why Roche paid $1.9 billion for a 5-year-old companyEarlier this month, Roche, a global pharmaceutical giant, acquired Flatiron Health, an oncology-focused electronic health records (EHR) company, for $1.9 billion. Prior to this, Roche had a 12.6% stake in the...
Industry Reports
InDex Pharmaceuticals Holding AB (publ) Year end Report 2017
Period October – December 2017 Revenues amounted to SEK 0.0 (0.3) million Operating result amounted to SEK –22.6 (–16.4) million Result after tax amounted to SEK –22.4 (–16.3) million,corresponding to SEK –0.36 per share (–0.27) before and after...
Industry Reports
Swedish Primary care group Novakliniken being acquired by Capio
Capio has signed an agreement to acquire 100% of Novakliniken with operations in the southeastern parts of Skåne, Sweden. Novakliniken operates eight primary care centers and two branches, and provides some occupational health and dental services. ...
Industry Reports
Reckitt Benckiser’s proposal to buy Pfizer makes sense says JP Morgan
Reckitt Benckiser Group PLC is attempting to buy Pfizer Inc’s consumer healthcare business and analysts at JP Morgan think a potential deal makes sense. “We see a potential acquisition as a strategic step toward building a...
Industry Reports
Merck signs its acquisition agreement with Viralytics to Increase its Leading Immuno-Oncolgy Pipeline
Merck , known as MSD outside the USA and Canada, and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded...
Industry Reports
Roche acquires a software company named Flatiron health
Swiss pharmaceutical giant Roche Group is buying Flatiron Health, an Alphabet-backed cancer-focused start-up founded by two former Google employees, according to sources familiar with the matter. The company will pay $1.9 billion, adding to its existing...
Industry Reports
Nuvo Pharmaceuticals Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC
Nuvo Pharmaceuticals Inc.™ , a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that its wholly owned subsidiary, Nuvo Pharmaceuticals (Ireland) Limited (Nuvo Ireland) has acquired the U.S. rights to Resultz® (50% isopropyl...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read